Jian-chun LIU, Hong-zhen ZHANG, Wen-juan GUO, et al. Neuroprotective Mechanism of Buyang Huanwu Tang on Experimental Autoimmune Encephalomyelitis Mice. [J]. Chinese Journal of Experimental Traditional Medical Formulae 25(14):55-61(2019)
DOI:
Jian-chun LIU, Hong-zhen ZHANG, Wen-juan GUO, et al. Neuroprotective Mechanism of Buyang Huanwu Tang on Experimental Autoimmune Encephalomyelitis Mice. [J]. Chinese Journal of Experimental Traditional Medical Formulae 25(14):55-61(2019) DOI: 10.13422/j.cnki.syfjx.20191340.
Neuroprotective Mechanism of Buyang Huanwu Tang on Experimental Autoimmune Encephalomyelitis Mice
To explore the neuroprotective effect and mechanism of Buyang Huanwu Tang (BYHWT) on experimental autoimmune encephalomyelitis (EAE) at different stages.
Method:
2
The 36 female C57BL/6 mice were immunized subcutaneously with myelin oligodendrocyte glycoprotein peptides (MOG
35-55
)
then randomly divided into 9
17
28 d EAE control group. Each BYHWT group was orally given drugs on the 3
rd
day after immunization (50 g·kg
-1
·d
-1
)
and EAE control group was given the same volume of normal saline in the same way once a day for 9
17 and 28 d after immunization. The effect of BYHWT on EAE mice was observed with internationally accepted clinical score. Brain and spinal cord specimens were collected at 9
17 and 28 d after immunization. The neuroprotective effect of BYHWT was observed by hematoxylin-eosin(HE)staining and solid blue staining (LFB). The expressions of BDNF and GAP-43 in spinal cord and brain were detected by Western blot.
Result:
2
After treatment
BYHWT can significantly inhibit myelitis cell infiltration and alleviate myelin loss. Compared with EAE group
the expression of Nogo-A in the spinal cord of each BYHWT group was significantly down-regulated (
P
<
0.01)
and the expression of BDNF in the spinal cord was significantly up-regulated (
P
<
0.05
P
<
0.01) in the BYHWT group 17 and 28 d group compared with EAE group 17 and 28 d group. Compared with EAE 9
17 d group
GAP-43 expression was significantly up-regulated in the spinal cord of BYHWT 9
17 d group (
P
<
0.01).
Conclusion:
2
BYHWT can improve the local nerve growth microenvironment and promote the expression of NTFs
LOU Z Y, CHEN C, HE Q, et al. Targeting CB 2 receptor as a neuroinflammatory modulator in experimental autoimmune encephalomyelitis [J].Mol Immunol, 2011, 49(3): 453-461.
Urban J L, Kumar V, Kono D H, et al. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy [J].Cell, 1988, 54(4): 577-592.
Herzog C, Otto T. Regeneration of olfactory receptor neurons following chemical lesion: time course and enhancement with growth factor administration [J].Brain Res, 1999, 849(1/2): 155-161.
O'kusky J R, Ye P, D'ercole A J. Insulin-like growth factor-1 promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development [J].J Neurosci, 2000, 20(22): 8435-8442.
Prinjha R, Moore S E, Vinson M, et al. Neurobiology: inhibitor of neurite outgrowth in humans [J].Nature, 2000, 403(6768): 383-384.
Kwon B K, LIU J, Messerer C, et al. Survival and regeneration of rubrospinal neurons 1 year after spinal cordinjury [J].Proc Natl Acad Sci USA, 2002, 99(5): 3246-3251.
de Groot D M, Coenen A J M, Verhofstad A, et al. In vivo induction of glial cell proliferation and axonal outgrowth and myelination by brain-derived neurotrophic factor [J].Mol Endocrinol, 2006, 20(11): 2987-2998.
XIAO J, Hughes R A, Lim J Y, et al. A small peptide mimetic of brain-derived neurotrophic factor promotes peripheral myelination [J].J Neurochem, 2013, 125(3): 386-398.
Frey D, Laux T, XU L, et al. Shared and unique roles of CAP23 and GAP-43 inaction regulation, neurite outgrowth, and anatomical plasticity [J].Cell Biol, 2000, 149(7): 1443-1454.
Gupta S K, Mishra R, Kusum S, et al. GAP-43 is essential for the neurotrophic effects of BDNF and positive AMPA receptor modulator S18986 [J].Cell Death Differ, 2009, 16 (4): 624-637.
Walmsley A R, Mir A K. Targeting the Nogo-A signalling pathway to promote recovery following acute cns injury [J].Curr Pharm Des, 2007, 13(24): 2470-2484.